Medication-related Osteonecrosis of the Jaws
Conditions
Interventions
None listed
Sponsors
Nagasaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing surgery for MRONJ by March 2023
Exclusion criteria
Exclusion criteria: Patients dose not have a bone sample available for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.preoperative imaging 2.histopathology of surgical specimen 3.bacteriology of surgical specimen 4.change in morphology and number of osteoclasts on surgical specimen 5.sort, administration duratio and drug holiday of antiresorptive agent 6.postoperative imaging 7.treatment results (curing) of MRONJ 8.each collected item age, sex, primary disease, diabetes, steroid, chemotherapy, leukocytes, lymphocyte, albumin, creatinine, site, stage, trigger, treatment | — |
Countries
Japan
Contacts
Public ContactSakiko Soutome
Nagasaki University Department of Oral Health, Medical and Dental Sciences, Graduate School of Biomed
Outcome results
None listed